Met Life Investment Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 10,818 shares of MDGL stock, worth $3.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,818
Previous 10,123 6.87%
Holding current value
$3.7 Million
Previous $2.15 Million 55.4%
% of portfolio
0.02%
Previous 0.01%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$202.45 - $354.85 $140,702 - $246,620
695 Added 6.87%
10,818 $3.34 Million
Q2 2024

Aug 13, 2024
BUY
$193.33 - $291.99 $490,478 - $740,778
2,537 Added 33.44%
10,123 $2.84 Million
Q1 2024

May 14, 2024
BUY
$171.37 - $283.23 $1.3 Million - $2.15 Million
7,586 New
7,586 $2.03 Million
Q4 2023

Feb 14, 2024
BUY
$120.4 - $237.13 $69,952 - $137,772
581 Added 8.1%
7,758 $1.8 Million
Q3 2023

May 09, 2024
BUY
$146.04 - $225.78 $72,289 - $111,761
495 Added 7.41%
7,177 $1.05 Million
Q2 2023

Apr 29, 2024
BUY
$203.88 - $312.0 $1.46 Million - $2.24 Million
7,177 New
7,177 $1.66 Million
Q2 2023

Aug 10, 2023
BUY
$203.88 - $312.0 $100,920 - $154,440
495 Added 7.41%
7,177 $1.66 Million
Q1 2023

May 09, 2024
BUY
$231.06 - $307.08 $1.54 Million - $2.05 Million
6,682 New
6,682 $1.62 Billion
Q1 2022

May 10, 2024
BUY
$55.89 - $101.89 $373,456 - $680,828
6,682 New
6,682 $655,000
Q1 2022

Mar 22, 2023
BUY
$55.89 - $101.89 $137,936 - $251,464
2,468 Added 58.57%
6,682 $655,000
Q1 2022

May 12, 2022
BUY
$55.89 - $101.89 $137,936 - $251,464
2,468 Added 58.57%
6,682 $656,000
Q4 2021

May 17, 2024
BUY
$72.34 - $95.09 $38,123 - $50,112
527 Added 14.29%
4,214 $357,000
Q4 2021

Jun 21, 2023
SELL
$72.34 - $95.09 $178,535 - $234,682
-2,468 Reduced 36.94%
4,214 $357,000
Q4 2021

Mar 22, 2023
BUY
$72.34 - $95.09 $38,123 - $50,112
527 Added 14.29%
4,214 $357,000
Q4 2021

Feb 15, 2022
BUY
$72.34 - $95.09 $38,123 - $50,112
527 Added 14.29%
4,214 $357,000
Q3 2021

Jun 21, 2023
SELL
$78.35 - $105.02 $234,658 - $314,534
-2,995 Reduced 44.82%
3,687 $294,000
Q2 2021

Jun 21, 2023
SELL
$97.2 - $137.59 $291,114 - $412,082
-2,995 Reduced 44.82%
3,687 $359,000
Q1 2021

May 17, 2024
SELL
$108.54 - $125.2 $423,197 - $488,154
-3,899 Reduced 51.4%
3,687 $431,000
Q1 2021

Jun 26, 2023
SELL
$108.54 - $125.2 $325,077 - $374,974
-2,995 Reduced 44.82%
3,687 $431 Million
Q4 2020

Jun 22, 2023
SELL
$110.06 - $133.7 $329,629 - $400,431
-2,995 Reduced 44.82%
3,687 $409,000
Q3 2020

Jun 26, 2023
SELL
$99.78 - $124.21 $298,841 - $372,008
-2,995 Reduced 44.82%
3,687 $437,000
Q2 2020

May 24, 2024
SELL
$60.13 - $125.71 $234,446 - $490,143
-3,899 Reduced 51.4%
3,687 $418 Million
Q2 2020

Jun 26, 2023
SELL
$60.13 - $125.71 $180,089 - $376,501
-2,995 Reduced 44.82%
3,687 $417,000
Q1 2020

Jul 12, 2023
SELL
$66.76 - $93.49 $199,946 - $280,002
-2,995 Reduced 44.82%
3,687 $246,000
Q4 2019

Jul 12, 2023
SELL
$84.28 - $118.5 $252,418 - $354,907
-2,995 Reduced 44.82%
3,687 $335,000
Q3 2019

Jul 12, 2023
SELL
$84.4 - $106.53 $252,778 - $319,057
-2,995 Reduced 44.82%
3,687 $317,000
Q3 2019

Mar 22, 2023
BUY
$84.4 - $106.53 $47,601 - $60,082
564 Added 18.06%
3,687 $317,000
Q3 2019

Nov 14, 2019
BUY
$84.4 - $106.53 $47,601 - $60,082
564 Added 18.06%
3,687 $318,000
Q2 2019

Jul 12, 2023
SELL
$91.13 - $142.5 $272,934 - $426,787
-2,995 Reduced 44.82%
3,687 $386,000
Q1 2019

Jul 13, 2023
SELL
$103.48 - $143.84 $368,285 - $511,926
-3,559 Reduced 53.26%
3,123 $391,000
Q4 2018

Jul 13, 2023
SELL
$94.77 - $215.54 $337,286 - $767,106
-3,559 Reduced 53.26%
3,123 $352,000
Q4 2018

Mar 22, 2023
SELL
$94.77 - $215.54 $167,458 - $380,859
-1,767 Reduced 36.13%
3,123 $352,000
Q4 2018

Feb 14, 2019
SELL
$94.77 - $215.54 $167,458 - $380,859
-1,767 Reduced 36.13%
3,123 $352,000
Q3 2018

Jul 13, 2023
SELL
$207.3 - $300.31 $737,780 - $1.07 Million
-3,559 Reduced 53.26%
3,123 $668,000
Q3 2018

Mar 22, 2023
SELL
$207.3 - $300.31 $371,481 - $538,155
-1,792 Reduced 26.82%
4,890 $1.05 Million
Q3 2018

Nov 14, 2018
BUY
$207.3 - $300.31 $453,779 - $657,378
2,189 Added 81.04%
4,890 $1.05 Million
Q2 2018

Aug 15, 2018
BUY
$101.55 - $313.9 $59,508 - $183,945
586 Added 27.71%
2,701 $755,000
Q4 2017

Feb 15, 2018
BUY
$39.35 - $97.37 $83,225 - $205,937
2,115
2,115 $194,000

Others Institutions Holding MDGL

# of Institutions
335
Shares Held
22.2M
Call Options Held
960K
Put Options Held
940K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.84B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email